Efficacy and safety of baricitinib for active rheumatoid arthritis in patients with an inadequate response to conventional synthetic or biological disease-modifying anti-rheumatic drugs: A meta-analysis of randomized controlled trials

The purpose of the present meta-analysis was to assess the efficacy and safety of baricitinib for active rheumatoid arthritis (RA) in patients with an inadequate response or intolerance to conventional synthetic or biological disease-modifying anti-rheumatic drugs (DMARDs). A total of 7 randomized c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhi-Peng, Zhang, Pei, Bai, Jian-Zhong, Liang, Yuan, He, Jin-Shan, Wang, Jing-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122435/
https://www.ncbi.nlm.nih.gov/pubmed/30186483
http://dx.doi.org/10.3892/etm.2018.6495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122435/
https://www.ncbi.nlm.nih.gov/pubmed/30186483
http://dx.doi.org/10.3892/etm.2018.6495

Ejemplares similares